Delladetsima J - Search Results

1

Significance of immune status, genotype and viral load in the severity of chronic hepatitis C in HIV infected haemophilia patients.

Delladetsima J, Katsarou O, Touloumi G, Vgenopoulou S, Hatzakis A, Karafoulidou A. Delladetsima J, et al. Haemophilia. 2002 Sep;8(5):668-73. doi: 10.1046/j.1365-2516.2002.00670.x. Haemophilia. 2002. PMID: 12199677

2

Factors associated with severity and disease progression in chronic hepatitis C.

Tassopoulos NC, Papatheodoridis GV, Katsoulidou A, Delladetsima JK, Sypsa V, Touloumi G, Nikandros M, Hatzakis A. Tassopoulos NC, et al. Among authors: delladetsima jk. Hepatogastroenterology. 1998 Sep-Oct;45(23):1678-83. Hepatogastroenterology. 1998. PMID: 9840128

3

IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.

Tassopoulos NC, Vafiadis I, Tsantoulas D, Syrokosta J, Hatzis G, Delladetsima JK, Demonakou M, Sypsa V, Hatzakis AE. Tassopoulos NC, et al. Among authors: delladetsima jk. J Interferon Cytokine Res. 2002 Mar;22(3):365-9. doi: 10.1089/107999002753675794. J Interferon Cytokine Res. 2002. PMID: 12034044 Clinical Trial.

4

Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.

Tassopoulos NC, Karvountzis G, Touloumi G, Delladetsima JK, Papatheodoridis GV, Katsoulidou A, Retalis G, Hatzakis A. Tassopoulos NC, et al. Among authors: delladetsima jk. Am J Gastroenterol. 1996 Sep;91(9):1734-8. Am J Gastroenterol. 1996. PMID: 8792690 Clinical Trial.

5

Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission.

Papatheodoridis GV, Katsoulidou A, Touloumi G, Delladetsima JK, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. Among authors: delladetsima jk. Eur J Gastroenterol Hepatol. 1996 May;8(5):469-75. Eur J Gastroenterol Hepatol. 1996. PMID: 8804876 Clinical Trial.

6

Significance of IgM anti-HCV core level in chronic hepatitis C.

Papatheodoridis GV, Delladetsima JK, Katsoulidou A, Sypsa V, Albrecht M, Michel G, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. Among authors: delladetsima jk. J Hepatol. 1997 Jul;27(1):36-41. doi: 10.1016/s0168-8278(97)80277-2. J Hepatol. 1997. PMID: 9252071

7

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.

Delladetsima JK, Boletis JN, Makris F, Psichogiou M, Kostakis A, Hatzakis A. Delladetsima JK, et al. Liver Transpl Surg. 1999 Jul;5(4):294-300. doi: 10.1002/lt.500050417. Liver Transpl Surg. 1999. PMID: 10388502 Free article.

8

Cholestatic syndromes in renal transplant recipients with HCV infection.

Boletis JN, Delladetsima JK, Makris F, Theodoropoulou H, Vgenopoulou S, Kostakis A, Hatzakis A. Boletis JN, et al. Among authors: delladetsima jk. Transpl Int. 2000;13 Suppl 1:S375-9. doi: 10.1007/s001470050365. Transpl Int. 2000. PMID: 11112036

9

Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.

Delladetsima JK, Makris F, Psichogiou M, Kostakis A, Hatzakis A, Boletis JN. Delladetsima JK, et al. Liver. 2001 Apr;21(2):81-8. doi: 10.1034/j.1600-0676.2001.021002081.x. Liver. 2001. PMID: 11318976

10

Clinicopathological assessment of hepatitis C virus infection in parenteral drug abusers.

Papatheodoridis GV, Delladetsima J, Verghisi-Nikolakaki S, Malliori M, Krystallis A, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. Among authors: delladetsima j. Am J Gastroenterol. 1995 Oct;90(10):1843-6. Am J Gastroenterol. 1995. PMID: 7572906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters